Prostatype Genomics registers TO6 warrant shares

Prostatype Genomics AB registered 123,069,257 TO6 warrant shares, lifting total shares to 683,160,762. A directed underwriter issue is expected to add 8,156,289 shares, bringing total to 691,317,051 once registered.